NEW YORK – CVS Health (NYSE: CVS) is exiting its core infusion services business and plans to either close or
1 year ago
BENGALURU – Novo Nordisk (NYSE: NVO), whose global profile has risen along with demand for its Wegovy weight-loss drug, is
Sanofi (NASDAQ: SNY) is closing in on a deal to sell its consumer health unit for about 15 billion euros
On Thursday, Indivior (NASDAQ: INDV), the British drugmaker, cut its 2024 net revenue forecast for the second time in three
NEW YORK – U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo
BERLIN – Switzerland’s COMCO competition commission terminated an investigation against Novartis (NYSE: NVS) into possibly using blocking patents, without consequences,
Shares of GSK (NYSE: GSK) rose about 6% on Wednesday after the British drugmaker struck a $2.2 billion settlement over
NEW YORK – CVS Health (NYSE: CVS), UnitedHealth Group (NYSE: UNH), and Cigna (NYSE: CI) have asked U.S. Federal Trade
The European Commission authorized Novavax’s (NASDAQ: NVAX) updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the
FRANKFURT – Fresenius (NYSE: FMS) said it was checking options to speed up the start of new production lines of
LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two
U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
